Back
Accenture PLC Vs. United Therapeutics Industry Stock Comparison
Sell
42
ACN
Accenture PLC
Last Price:
$271.00
Seasonality Move:
0.8%
Sell
38
UTHR
United Therapeutics
Last Price:
$279.02
Seasonality Move:
4.42%
Sell
42
Accenture PLC (ACN)
is a Sell
Is Accenture PLC a Buy, Sell or Hold?
-
The current Accenture PLC [ACN] share price is $274.00. The Score for ACN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $281.95. The Score for UTHR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACN Stock Price Chart
What is Accenture PLC's stock price today?
-
The Accenture PLC share price today is $274.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACN is experiencing slight selling pressure.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $281.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
ACN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.39 | Sell |
Relative Strength Index (14 RSI): | 34.05 | Sell |
Chaikin Money Flow: | -2088897 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (279 - 298.32) | Sell |
Bollinger Bands (100): | (287.58 - 318.8) | Sell |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 40.82 | Buy |
Relative Strength Index (14 RSI): | 37.59 | Sell |
Chaikin Money Flow: | -858285 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (288.25 - 301.11) | Sell |
Bollinger Bands (100): | (288.14 - 312.96) | Sell |
ACN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 281.28 | Sell |
20-day SMA: | 286.44 | Sell |
50-day SMA: | 300.86 | Sell |
200-day SMA: | 333.18 | Sell |
8-day EMA: | 279.98 | Sell |
20-day EMA: | 285.76 | Sell |
50-day EMA: | 295.9 | Sell |
200-day EMA: | 319.37 | Sell |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 298.15 | Sell |
20-day SMA: | 296.72 | Sell |
50-day SMA: | 299.73 | Sell |
200-day SMA: | 331.87 | Sell |
8-day EMA: | 114.09 | Buy |
20-day EMA: | 52.49 | Buy |
50-day EMA: | 22.27 | Buy |
200-day EMA: | 5.74 | Buy |
Accenture PLC Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.03 per share, an increase this year of $0.97 per share, and an increase next year of $0.94 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, an increase next quarter of $0.96 per share, an increase this year of $2.25 per share, and an increase next year of $1.33 per share.
Accenture PLC Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |